T80.82XS Complication of immune effector cellular therapy, sequela
Billable / valid for submission ICD10CM Release FY2026
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | current | Complication of immune effector cellular therapy, sequela | yes |
Related codes in T80
- T80 Complications following infusion, transfusion and therapeutic injection
- T80.0 Air embolism following infusion, transfusion and therapeutic injection
- T80.0XXA Air embolism following infusion, transfusion and therapeutic injection, initial encounter
- T80.0XXD Air embolism following infusion, transfusion and therapeutic injection, subsequent encounter
- T80.0XXS Air embolism following infusion, transfusion and therapeutic injection, sequela
- T80.1 Vascular complications following infusion, transfusion and therapeutic injection
- T80.1XXA Vascular complications following infusion, transfusion and therapeutic injection, initial encounter
- T80.1XXD Vascular complications following infusion, transfusion and therapeutic injection, subsequent encounter
- T80.1XXS Vascular complications following infusion, transfusion and therapeutic injection, sequela
- T80.2 Infections following infusion, transfusion and therapeutic injection
- T80.21 Infection due to central venous catheter
- T80.211 Bloodstream infection due to central venous catheter
- T80.211A Bloodstream infection due to central venous catheter, initial encounter
- T80.211D Bloodstream infection due to central venous catheter, subsequent encounter
- T80.211S Bloodstream infection due to central venous catheter, sequela
- T80.212 Local infection due to central venous catheter
- T80.212A Local infection due to central venous catheter, initial encounter
- T80.212D Local infection due to central venous catheter, subsequent encounter
- T80.212S Local infection due to central venous catheter, sequela
- T80.218 Other infection due to central venous catheter